{"id":7534,"date":"2025-04-10T09:06:08","date_gmt":"2025-04-10T09:06:08","guid":{"rendered":"https:\/\/tst.incliva.es\/?page_id=7534"},"modified":"2025-04-10T09:06:08","modified_gmt":"2025-04-10T09:06:08","slug":"carlos-solano-vercet","status":"publish","type":"page","link":"https:\/\/tst.incliva.es\/en\/carlos-solano-vercet\/","title":{"rendered":"Carlos Solano Vercet"},"content":{"rendered":"<p><div class=\"fusion-fullwidth fullwidth-box fusion-builder-row-1 fusion-flex-container fusion-parallax-none nonhundred-percent-fullwidth non-hundred-percent-height-scrolling\" style=\"background-color: #ededed;background-image: url(&quot;https:\/\/www.incliva.es\/wp-content\/uploads\/2021\/01\/fondo.jpg&quot;);background-position: center center;background-repeat: no-repeat;border-width: 0px 0px 0px 0px;border-color:#e2e2e2;border-style:solid;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;\" ><div class=\"fusion-builder-row fusion-row fusion-flex-align-items-flex-start\" style=\"max-width:1248px;margin-left: calc(-4% \/ 2 );margin-right: calc(-4% \/ 2 );\">\n<div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-0 fusion_builder_column_3_4 3_4 fusion-flex-column\"><div class=\"fusion-column-wrapper fusion-flex-justify-content-flex-start fusion-content-layout-column\" style=\"background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;padding: 0px 0px 0px 0px;\">\n<div class=\"fusion-text fusion-text-1\" style=\"transform:translate3d(0,0,0);\"><h3>Dr. Carlos Solano Vercet<\/h3>\n<\/div>\n<div class=\"fusion-separator fusion-full-width-sep\" style=\"align-self: center;margin-left: auto;margin-right: auto;margin-bottom:3px;width:100%;\"><div class=\"fusion-separator-border sep-single sep-solid\" style=\"border-color:#9da0d2;border-top-width:1px;\"><\/div><\/div>\n<div class=\"fusion-text fusion-text-2\" style=\"transform:translate3d(0,0,0);\"><h5><span style=\"color: #3D44AC;\">Principal Investigator<br \/>\nResearch Group on Hematopoietic Transplantation<br \/>\n<\/span><\/h5>\n<\/div>\n<div class=\"fusion-separator fusion-full-width-sep\" style=\"align-self: center;margin-left: auto;margin-right: auto;margin-bottom:10px;width:100%;\"><div class=\"fusion-separator-border sep-single sep-solid\" style=\"border-color:#9da0d2;border-top-width:1px;\"><\/div><\/div>\n<div class=\"fusion-text fusion-text-3\" style=\"transform:translate3d(0,0,0);\"><h4 style=\"text-align: justify;\">Presentation<\/h4>\n<\/div>\n<\/div><\/div><style type=\"text\/css\">.fusion-body .fusion-builder-column-0{width:75% !important;margin-top : 0px;margin-bottom : 20px;}.fusion-builder-column-0 > .fusion-column-wrapper {padding-top : 0px !important;padding-right : 0px !important;margin-right : 2.56%;padding-bottom : 0px !important;padding-left : 0px !important;margin-left : 2.56%;}@media only screen and (max-width:1532px) {.fusion-body .fusion-builder-column-0{width:75% !important;}.fusion-builder-column-0 > .fusion-column-wrapper {margin-right : 2.56%;margin-left : 2.56%;}}@media only screen and (max-width:640px) {.fusion-body .fusion-builder-column-0{width:100% !important;}.fusion-builder-column-0 > .fusion-column-wrapper {margin-right : 1.92%;margin-left : 1.92%;}}<\/style>\n<div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-1 fusion_builder_column_1_4 1_4 fusion-flex-column\"><div class=\"fusion-column-wrapper fusion-flex-justify-content-flex-start fusion-content-layout-column\" style=\"background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;background-color:#ffffff;border-width: 0 0 0 2px;border-color:#9da0d2;border-style:solid;padding: 4% 4% 4% 4%;\">\n<div ><span class=\" fusion-imageframe imageframe-none imageframe-1 hover-type-none\" style=\"border-radius:5px;\"><img src=\"\/wp-content\/uploads\/2022\/10\/Carlos-Solano-Vercet_FIH15.jpg\" class=\"img-responsive\"\/><\/span><\/div>\n<div class=\"fusion-separator fusion-full-width-sep\" style=\"align-self: center;margin-left: auto;margin-right: auto;margin-top:10px;margin-bottom:10px;width:100%;\"><\/div>\n<div class=\"fusion-text fusion-text-4\" style=\"transform:translate3d(0,0,0);\"><h5 style=\"text-align: center;\">Principal<br \/>\nInvestigator<\/h5>\n<div style=\"text-align: center;\">Dr. Carlos Solano Vercet<\/div>\n<p style=\"text-align: center;\"><a href=\"mailto:carlos.solano@uv.es\">carlos.solano@uv.es<\/a><\/p>\n<\/div>\n<\/div><\/div><style type=\"text\/css\">.fusion-body .fusion-builder-column-1{width:25% !important;margin-top : 0px;margin-bottom : 20px;}.fusion-builder-column-1 > .fusion-column-wrapper {padding-top : 4% !important;padding-right : 4% !important;margin-right : 7.68%;padding-bottom : 4% !important;padding-left : 4% !important;margin-left : 7.68%;}@media only screen and (max-width:1532px) {.fusion-body .fusion-builder-column-1{width:25% !important;order : 0;}.fusion-builder-column-1 > .fusion-column-wrapper {margin-right : 7.68%;margin-left : 7.68%;}}@media only screen and (max-width:640px) {.fusion-body .fusion-builder-column-1{width:100% !important;order : 0;}.fusion-builder-column-1 > .fusion-column-wrapper {margin-right : 1.92%;margin-left : 1.92%;}}<\/style>\n<\/div>\n<style type=\"text\/css\">.fusion-fullwidth.fusion-builder-row-1 { overflow:visible; }.fusion-body .fusion-flex-container.fusion-builder-row-1{ padding-top : 2%;margin-top : 0px;padding-right : 0px;padding-bottom : 0px;margin-bottom : 0px;padding-left : 0px;}<\/style><\/div><br \/>\n<div class=\"fusion-fullwidth fullwidth-box fusion-builder-row-2 fusion-flex-container nonhundred-percent-fullwidth non-hundred-percent-height-scrolling\" style=\"background-color: #e5e5e5;background-position: center center;background-repeat: no-repeat;border-width: 0px 0px 0px 0px;border-color:#e2e2e2;border-style:solid;\" ><div class=\"fusion-builder-row fusion-row fusion-flex-align-items-flex-start\" style=\"max-width:1248px;margin-left: calc(-4% \/ 2 );margin-right: calc(-4% \/ 2 );\">\n<div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-2 fusion_builder_column_1_1 1_1 fusion-flex-column\"><div class=\"fusion-column-wrapper fusion-flex-justify-content-flex-start fusion-content-layout-column\" style=\"background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;padding: 0px 0px 0px 0px;\">\n<div class=\"fusion-text fusion-text-5\" style=\"transform:translate3d(0,0,0);\"><h5>Publications<\/h5>\n<\/div>\n<div class=\"fusion-tabs fusion-tabs-1 classic horizontal-tabs icon-position-left\"><style type=\"text\/css\">.fusion-tabs.fusion-tabs-1 .nav-tabs li a.tab-link{border-top-color:#f9f9fb;background-color:#f9f9fb;}.fusion-tabs.fusion-tabs-1 .nav-tabs{background-color:#ffffff;}.fusion-tabs.fusion-tabs-1 .nav-tabs li.active a.tab-link,.fusion-tabs.fusion-tabs-1 .nav-tabs li.active a.tab-link:hover,.fusion-tabs.fusion-tabs-1 .nav-tabs li.active a.tab-link:focus{border-right-color:#ffffff;}.fusion-tabs.fusion-tabs-1 .nav-tabs li.active a.tab-link,.fusion-tabs.fusion-tabs-1 .nav-tabs li.active a.tab-link:hover,.fusion-tabs.fusion-tabs-1 .nav-tabs li.active a.tab-link:focus{background-color:#ffffff;}.fusion-tabs.fusion-tabs-1 .nav-tabs li a:hover{background-color:#ffffff;border-top-color:#ffffff;}.fusion-tabs.fusion-tabs-1 .tab-pane{background-color:#ffffff;}.fusion-tabs.fusion-tabs-1 .nav,.fusion-tabs.fusion-tabs-1 .nav-tabs,.fusion-tabs.fusion-tabs-1 .tab-content .tab-pane{border-color:#e2e2e2;}<\/style><div class=\"nav\"><ul class=\"nav-tabs nav-justified\" role=\"tablist\"><li class=\"active\"><a class=\"tab-link\" data-toggle=\"tab\" role=\"tab\" aria-controls=\"tab-f10cc5ad8ff0673dc0e\" aria-selected=\"true\" id=\"fusion-tab-2024\" href=\"#tab-f10cc5ad8ff0673dc0e\"><h4 class=\"fusion-tab-heading\">2024<\/h4><\/a><\/li><li><a class=\"tab-link\" data-toggle=\"tab\" role=\"tab\" aria-controls=\"tab-09599d8013989ef7a46\" aria-selected=\"false\" tabindex=\"-1\" id=\"fusion-tab-2023\" href=\"#tab-09599d8013989ef7a46\"><h4 class=\"fusion-tab-heading\">2023<\/h4><\/a><\/li><li><a class=\"tab-link\" data-toggle=\"tab\" role=\"tab\" aria-controls=\"tab-da6675919f212aca7e7\" aria-selected=\"false\" tabindex=\"-1\" id=\"fusion-tab-2022\" href=\"#tab-da6675919f212aca7e7\"><h4 class=\"fusion-tab-heading\">2022<\/h4><\/a><\/li><li><a class=\"tab-link\" data-toggle=\"tab\" role=\"tab\" aria-controls=\"tab-73e62403f21662cb1a5\" aria-selected=\"false\" tabindex=\"-1\" id=\"fusion-tab-2021\" href=\"#tab-73e62403f21662cb1a5\"><h4 class=\"fusion-tab-heading\">2021<\/h4><\/a><\/li><\/ul><\/div><div class=\"tab-content\"><div class=\"nav fusion-mobile-tab-nav\"><ul class=\"nav-tabs nav-justified\"><li class=\"active\"><a class=\"tab-link\" data-toggle=\"tab\" role=\"tab\" aria-controls=\"tab-f10cc5ad8ff0673dc0e\" aria-selected=\"true\" id=\"mobile-fusion-tab-2024\" href=\"#tab-f10cc5ad8ff0673dc0e\"><h4 class=\"fusion-tab-heading\">2024<\/h4><\/a><\/li><\/ul><\/div><div class=\"tab-pane fade fusion-clearfix in active\" role=\"tabpanel\" tabindex=\"0\" aria-labelledby=\"fusion-tab-2024\" id=\"tab-f10cc5ad8ff0673dc0e\">\n<div style=\"padding-top:4%;padding-left:4%; padding-right:4%; text-align:justify;\">\nGraft-versus-host-disease prophylaxis with ATG or PTCY in patients with lymphoproliferative disorders undergoing reduced intensity conditioning regimen HCT from one antigen mismatched unrelated donor. Paviglianiti A, Ngoya M, Pena M, Boumendil A, Guelbas Z, Ciceri F, Bonifazi F, Russo D, Fegueux N, Stolzel F, Bulabois C, Socie G, Forcade E, Solano C, Finel H, Robinson S, Glass B, Montoto S. Bone Marrow Transplantation. 2024 Feb 8. doi: <a href='https:\/\/doi.org\/10.1038\/s41409-024-02225-2' target='_blank'>10.1038\/s41409-024-02225-2<\/a>. PMID: <a href='https:\/\/pubmed.ncbi.nlm.nih.gov\/38331980' target='_blank'>38331980<\/a><\/p>\n<p>Prophylaxis and management of graft-versus-host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation. Penack O, Marchetti M, Aljurf M, Arat M, Bonifazi F, Duarte R, Giebel S, Greinix H, Hazenberg M, Kroger N, Mielke S, Mohty M, Nagler A, Passweg J, Patriarca F, Ruutu T, Schoemans H, Solano C, Vrhovac R, Wolff D, Zeiser R, Sureda A, Peric Z. Lancet. Haematology. 2024 Jan 3:S2352-3026(23)00342-3. doi: <a href='https:\/\/doi.org\/10.1016\/S2352-3026(23)00342-3' target='_blank'>10.1016\/S2352-3026(23)00342-3<\/a>. PMID: <a href='https:\/\/pubmed.ncbi.nlm.nih.gov\/38184001' target='_blank'>38184001<\/a><\/p>\n<p>Upper and\/or lower respiratory tract infection caused by human metapneumovirus after allogeneic hematopoietic stem cell transplantation. Pi\u00f1ana JL, Tridello G, Xhaard A, Wendel L, Montoro J, Vazquez L, Heras I, Ljungman P, Mikulska M, Salmenniemi U, Perez A, Kr\u00f6ger N, Cornelissen JJ, Sala E, Martino R, Geurten C, Byrne J, Maertens J, Kerre T, Martin M, Pascual MJ, Yeshurun M, Finke J, Groll AH, Shaw PJ, Blijlevens N, Arcese W, Ganser A, Suarez-Lledo M, Alzahrani M, Choi G, Forcade E, Paviglianiti A, Solano C, Wachowiak J, Zuckerman T, Bader P, Clausen J, Mayer J, Schroyens W, Metafuni E, Knelange N, Averbuch D, de la Camara R. The Journal of Infectious Diseases. 2024 Jan 12;229(1):83-94. doi: <a href='https:\/\/doi.org\/10.1093\/infdis\/jiad268' target='_blank'>10.1093\/infdis\/jiad268<\/a>. PMID: <a href='https:\/\/pubmed.ncbi.nlm.nih.gov\/37440459' target='_blank'>37440459<\/a><\/p>\n<\/div>\n<\/div><div class=\"nav fusion-mobile-tab-nav\"><ul class=\"nav-tabs nav-justified\"><li><a class=\"tab-link\" data-toggle=\"tab\" role=\"tab\" aria-controls=\"tab-09599d8013989ef7a46\" aria-selected=\"false\" tabindex=\"-1\" id=\"mobile-fusion-tab-2023\" href=\"#tab-09599d8013989ef7a46\"><h4 class=\"fusion-tab-heading\">2023<\/h4><\/a><\/li><\/ul><\/div><div class=\"tab-pane fade fusion-clearfix\" role=\"tabpanel\" tabindex=\"0\" aria-labelledby=\"fusion-tab-2023\" id=\"tab-09599d8013989ef7a46\">\n<div style=\"padding-top:4%;padding-left:4%; padding-right:4%; text-align:justify;\">\nAssessment of the potential value of plasma Torque Teno virus DNA load monitoring to predict cytomegalovirus DNAemia in patients with hematological malignancies treated with small molecule inhibitors: a proof-of-concept study. de la Asunci\u00f3n C, Gim\u00e9nez E, Hern\u00e1ndez-Boluda J, Terol M, Albert E, L\u00f3pez J, Garc\u00eda-Guti\u00e9rrez V, Andreu R, Malo M, Fox M, Remigia M, Amat P, Solano C, Navarro D. Journal of Medical Virology. 2023 Jul;95(7):e28933. doi: <a href='https:\/\/doi.org\/10.1002\/jmv.28933' target='_blank'>10.1002\/jmv.28933<\/a>. PMID: <a href='https:\/\/pubmed.ncbi.nlm.nih.gov\/37403897' target='_blank'>37403897<\/a><\/p>\n<p>Cytomegalovirus DNAemia in hematological patients undergoing CD19-directed CAR-T cell therapy: should it be systematically monitored?. Solano de la Asuncion C, Hernani R, Albert E, Gomez M, Gimenez E, Benzaquen A, Gonzalez-Barbera E, Hernandez-Boluda J, Perez A, Pinana J, Chorao P, Guerreiro M, Montoro J, Sanz J, Solano C, Navarro D. Clinical Microbiology and Infection. 2023 Aug;29(8):1093-1095. doi: <a href='https:\/\/doi.org\/10.1016\/j.cmi.2023.05.010' target='_blank'>10.1016\/j.cmi.2023.05.010<\/a>. PMID: <a href='https:\/\/pubmed.ncbi.nlm.nih.gov\/37182642' target='_blank'>37182642<\/a><\/p>\n<p>Features of cytomegalovirus DNAemia and virus-specific T-cell responses in allogeneic hematopoietic stem-cell transplant recipients during prophylaxis with letermovir. Gimenez E, Guerreiro M, Torres I, Aguilar C, Albert E, Hernandez-Boluda JC, Hernani R, Perez A, Amat P, Pinana JL, Montoro J, Solano C, Navarro D. Transplant Infectious Disease. 2023 Apr;25(2):e14021. doi: <a href='https:\/\/doi.org\/10.1111\/tid.14021' target='_blank'>10.1111\/tid.14021<\/a>. PMID: <a href='https:\/\/pubmed.ncbi.nlm.nih.gov\/36748748' target='_blank'>36748748<\/a><\/p>\n<p>Immunobiology of cytomegalovirus infection in patients with haematological malignancies undergoing treatment with small molecule inhibitors. Solano De la Asuncion C, Gimenez E, Hernandez-Boluda JC, Terol MJ, Albert E, Lopez-Jimenez J, Garcia-Gutierrez V, Andreu R, Garcia D, Fox ML, Remigia MJ, Amat P, Solano C, Navarro D. British Journal of Haematology. 2023 Mar;200(6):e58-e61. doi: <a href='https:\/\/doi.org\/10.1111\/bjh.18655' target='_blank'>10.1111\/bjh.18655<\/a>. PMID: <a href='https:\/\/pubmed.ncbi.nlm.nih.gov\/36652997' target='_blank'>36652997<\/a><\/p>\n<p>Immunovirology of cytomegalovirus infection in allogeneic stem cell transplant recipients undergoing prophylaxis with letermovir: a narrative review. Solano C, Gim\u00e9nez E, Albert E, Pi\u00f1ana J, Navarro D. Journal of Medical Virology. 2023 Aug;95(8):e29005. doi: <a href='https:\/\/doi.org\/10.1002\/jmv.29005' target='_blank'>10.1002\/jmv.29005<\/a>. PMID: <a href='https:\/\/pubmed.ncbi.nlm.nih.gov\/37526411' target='_blank'>37526411<\/a><\/p>\n<style type=\"text\/css\">.fusion-accordian  #accordion-7534-1 .panel-title a .fa-fusion-box{ color: #ffffff;}.fusion-accordian  #accordion-7534-1 .panel-title a .fa-fusion-box:before{ font-size: 14px; width: 14px;}.fusion-accordian  #accordion-7534-1.fusion-toggle-icon-right .fusion-toggle-heading{ margin-right: 32px;}.fusion-accordian  #accordion-7534-1 .panel-title a{font-size:14px;}.fusion-accordian  #accordion-7534-1 .fa-fusion-box { background-color: #212934;border-color: #212934;}.fusion-accordian  #accordion-7534-1 .panel-title a:hover, #accordion-7534-1 .fusion-toggle-boxed-mode:hover .panel-title a { color: #3bafbf;}.fusion-accordian  #accordion-7534-1 .panel-title .active .fa-fusion-box,.fusion-accordian  #accordion-7534-1 .panel-title a:hover .fa-fusion-box { background-color: #3bafbf!important;border-color: #3bafbf!important;}<\/style><div class=\"accordian fusion-accordian\"><div class=\"panel-group fusion-toggle-icon-right\" id=\"accordion-7534-1\" role=\"tablist\">\n<div class=\"fusion-panel panel-default\" role=\"tabpanel\"><div class=\"panel-heading\"><h4 class=\"panel-title toggle\"><a aria-expanded=\"false\" aria-selected=\"false\" aria-controls=\"71f9a882301da067f\" role=\"tab\" data-toggle=\"collapse\" data-parent=\"#accordion-7534-1\" data-target=\"#71f9a882301da067f\" href=\"#71f9a882301da067f\"><span class=\"fusion-toggle-icon-wrapper\" aria-hidden=\"true\"><i class=\"fa-fusion-box\" aria-hidden=\"true\"><\/i><\/span><span class=\"fusion-toggle-heading\">More publications from 2023<\/span><\/a><\/h4><\/div><div id=\"71f9a882301da067f\" class=\"panel-collapse collapse \"><div class=\"panel-body toggle-content fusion-clearfix\">\nImpact of cytomegalovirus immunodominant HLA-I donor-recipient matching on the incidence and features of virus DNAemia and virus-specific T-cell immune reconstitution in unmanipulated haploidentical hematopoietic stem cell transplantation. Huntley D, Gimenez E, Vazquez L, Pascual M, Amat P, Remigia M, Hernandez-Boluda J, Garcia M, Gago B, Torres I, de la Asuncion C, Hernani R, Perez A, Albert E, Pinana J, Solano C, Navarro D. Transplant Infectious Disease. 2023 Jun;25(3):e14065. doi: <a href='https:\/\/doi.org\/10.1111\/tid.14065' target='_blank'>10.1111\/tid.14065<\/a>. PMID: <a href='https:\/\/pubmed.ncbi.nlm.nih.gov\/37120821' target='_blank'>37120821<\/a><\/p>\n<p>Improved outcomes over time and higher mortality in CMV seropositive allogeneic stem cell transplantation patients with COVID-19; An infectious disease working party study from the European Society for Blood and Marrow Transplantation registry. Ljungman P, Tridello G, Pinana J, Ciceri F, Sengeloev H, Kulagin A, Mielke S, Yegin Z, Collin M, Einardottir S, Lepretre S, Maertens J, Campos A, Metafuni E, Pichler H, Folber F, Solano C, Nicholson E, Yuksel M, Carlson K, Aguado B, Besley C, Byrne J, Heras I, Dignan F, Kroger N, Robin C, Khan A, Lenhoff S, Grassi A, Dobsinska V, Miranda N, Jimenez M, Yonal-Hindilerden I, Wilson K, Averbuch D, Cesaro S, Xhaard A, Knelange N, Styczynski J, Mikulska M, de la Camara R. Frontiers in Immunology. 2023 Mar 7;14:1125824. doi: <a href='https:\/\/doi.org\/10.3389\/fimmu.2023.1125824' target='_blank'>10.3389\/fimmu.2023.1125824<\/a>. PMID: <a href='https:\/\/pubmed.ncbi.nlm.nih.gov\/36960069' target='_blank'>36960069<\/a><\/p>\n<p>In vitro assessment of the combined effect of letermovir and sirolimus on cytomegalovirus replication. Gimenez E, Guerreiro M, Gozalbo-Rovira R, Aguilar C, Albert E, Pinana J, Solano C, Navarro D. Revista Espanola de Quimioterapia. 2023 Oct;36(5):526-530. doi: <a href='https:\/\/doi.org\/10.37201\/req\/016.2023' target='_blank'>10.37201\/req\/016.2023<\/a>. PMID: <a href='https:\/\/pubmed.ncbi.nlm.nih.gov\/37365797' target='_blank'>37365797<\/a><\/p>\n<p>Incidence and prognostic impact of U2AF1 mutations and other gene alterations in myelodysplastic neoplasms with isolated 20q deletion. Martin Castillo I, Villamon Ribate E, Calabuig Munoz M, Sanz Santillana G, Such Taboada E, Mora Castera E, Calasanz Abinzano MJ, Irigoyen Barranco A, Collado Nieto R, Vara Pampliega M, Blanco ML, Alvarez de Andres S, Perez de Oteyza J, Bernal del Castillo T, Granada Font I, Jerez Cayuela A, Diez-Campelo M, Abellan Sanchez R.; Solano Vercet C, Tormo Diaz M. Cancer Medicine. 2023 Aug;12(16):16788-16792. doi: <a href='https:\/\/doi.org\/10.1002\/cam4.6300' target='_blank'>10.1002\/cam4.6300<\/a>. PMID: <a href='https:\/\/pubmed.ncbi.nlm.nih.gov\/37403747' target='_blank'>37403747<\/a><\/p>\n<p>Monitoring for virus-specific T-cell responses and viremia in allogeneic HSCT recipients: a survey from the EBMT Cellular Therapy &#038; Immunobiology Working Party. Greco R, Hoogenboom JD, Bonneville EF, Anagnostopoulos A, Cuoghi A, Dalle JH, Weissinger EM, Lang P, Galaverna F, Martino M, Maschan A, Mauz-Korholz C, Noviello M, Passweg J, Peccatori J, Rovira M, Solano C, Veelken H, Velardi A, Wagner-Drouet EM, Zhang X, Ciceri F, Bonini C, Vago L, Ruggeri A, Chabannon C. Bone Marrow Transplantation. 2023 May;58(5):603-606. doi: <a href='https:\/\/doi.org\/10.1038\/s41409-023-01939-z' target='_blank'>10.1038\/s41409-023-01939-z<\/a>. PMID: <a href='https:\/\/pubmed.ncbi.nlm.nih.gov\/36813866' target='_blank'>36813866<\/a><\/p>\n<p>Monitoring of plasma Torque teno virus, total Anelloviridae and Human Pegivirus 1 viral load for the prediction of infectious events and acute graft versus host disease in the allogeneic hematopoietic stem cell transplantation setting. Forqu\u00e9 L, Albert E, Pi\u00f1ana JL, P\u00e9rez A, Hernani R, Solano C, Navarro D, Gim\u00e9nez E. Journal of Medical Virology. 2023 Sep;95(9):e29107. doi: <a href='https:\/\/doi.org\/10.1002\/jmv.29107' target='_blank'>10.1002\/jmv.29107<\/a>. PMID: <a href='https:\/\/pubmed.ncbi.nlm.nih.gov\/37721473' target='_blank'>37721473<\/a><\/p>\n<p>One-year breakthrough SARS-CoV-2 infection and correlates of protection in fully vaccinated hematological patients. Pinana JL, Vazquez L, Calabuig M, Lopez-Corral L, Martin-Martin G, Villalon L, Sanz-Linares G, Conesa-Garcia V, Sanchez-Salinas A, Gago B, Facal A, Risco-Galvez I, Olave MT, Espigado I, Lopez-Jimenez J, Hernandez-Rivas JA, Avendano-Pita A, Arroyo I, Ferrer E, Garcia-Cadenas I, Gonzalez-Santillana C, Roldan-Perez A, Ferrer B, Guerreiro M, Suarez-Lledo M, Camara A, Campos-Beltran D, Navarro D, Cedillo A, Sureda A, Solano C, Martino R. Blood Cancer Journal. 2023 Jan 5;13(1):8. doi: <a href='https:\/\/doi.org\/10.1038\/s41408-022-00778-3' target='_blank'>10.1038\/s41408-022-00778-3<\/a>. PMID: <a href='https:\/\/pubmed.ncbi.nlm.nih.gov\/36599843' target='_blank'>36599843<\/a><\/p>\n<p>Post-transplant cyclophosphamide-based graft-versus-host disease prophylaxis in HLA-matched and haploidentical donor transplants for patients with Hodgkin lymphoma: a comparative study of the LWP EBMT.: GVHD prophylaxis for patients with Hodgkin lymphoma. Montoro J, Boumendil A, Finel H, Bramanti S, Castagna L, Blaise D, Dominietto A, Kulagin A, Yakoub-Agha I, Tbakhi A, Solano C, Giebel S, Gulbas Z, L\u00f3pez Corral L, P\u00e9rez-Sim\u00f3n JA, D\u00edez Mart\u00edn JL, Sanz J, Farina L, Koc Y, Soci\u00e9 G, Arat M, Jurado M, Bermudez A, Labussi\u00e8re-Wallet H, Villalba M, Ciceri F, Martinez C, Nagler A, Sureda A, Glass B. Transplantation and Cellular Therapy. 2023 Dec 1:S2666-6367(23)01710-4. doi: <a href='https:\/\/doi.org\/10.1016\/j.jtct.2023.11.021' target='_blank'>10.1016\/j.jtct.2023.11.021<\/a>. PMID: <a href='https:\/\/pubmed.ncbi.nlm.nih.gov\/38043802' target='_blank'>38043802<\/a><\/p>\n<p>Quantifying the available capacity and resource needs for provision of CAR-T therapies in the National Health Service in Spain: a survey-based study. Solano C, Castro-Rebollo P, Perez-Martinez A, L\u00f3pez-Corral L, Barba-Su\u00f1ol P, Kwon M, Ortiz V, Sanz-Caballer J, Caballero A, Martinez J, Cedillo A, Sureda A. BMJ Open. 2023 Jul 25;13(7):e071371. doi: <a href='https:\/\/doi.org\/10.1136\/bmjopen-2022-071371' target='_blank'>10.1136\/bmjopen-2022-071371<\/a>. PMID: <a href='https:\/\/pubmed.ncbi.nlm.nih.gov\/37491085' target='_blank'>37491085<\/a><\/p>\n<p>Rationale for combined therapies in severe-to-critical COVID-19 patients. Gonzaga A, Andreu E, Hern\u00e1ndez-Blasco L, Meseguer R, Al-Akioui-Sanz K, Soria-Juan B, Sanjuan-Gimenez J, Ferreras C, Tejedo J, Lopez-Lluch G, Goterris R, Maci\u00e1 L, Sempere-Ortells J, Hmadcha A, Borobia A, Vicario J, Bonora A, Aguilar-Gallardo C, Poveda J, Arbona C, Alenda C, Tar\u00edn F, Marco F, Merino E, Jaime F, Ferreres J, Figueira J, Ca\u00f1ada-Illana C, Querol S, Guerreiro M, Eguizabal C, Martin-Quir\u00f3s A, Robles-Marhuenda A, P\u00e9rez-Mart\u00ednez A, Solano C, Soria B. Frontiers in Immunology. 2023 Sep 11:14:1232472. doi: <a href='https:\/\/doi.org\/10.3389\/fimmu.2023.1232472' target='_blank'>10.3389\/fimmu.2023.1232472<\/a>. PMID: <a href='https:\/\/pubmed.ncbi.nlm.nih.gov\/37767093' target='_blank'>37767093<\/a><\/p>\n<p>Recommendations on the use of azole antifungals in hematology-oncology patients. Azanza J, Mensa J, Barberan J, Vazquez L, Perez de Oteyza J, Kwon M, Yanez L, Aguado J, Cubillo Gracian A, Ruiz Camps I, Fortun J, Salavert Lleti M, Gudiol C, Olave Rubio T, Solano C, Garcia-Vidal C, Rovira Tarrats M, Suarez-Lledo Grande M, Gonzalez-Sierra P, Duenas Gutierrez C. Revista Espanola de Quimioterapia. 2023 Jun;36(3):236-258. doi: <a href='https:\/\/doi.org\/10.37201\/req\/013.2023' target='_blank'>10.37201\/req\/013.2023<\/a>. PMID: <a href='https:\/\/pubmed.ncbi.nlm.nih.gov\/37017117' target='_blank'>37017117<\/a><\/p>\n<p>Remdesivir or nirmatrelvir\/ritonavir therapy for omicron SARS-CoV-2 infection in hematological patients and cell therapy recipients. Pi\u00f1ana J, Heras I, Aiello T, Garc\u00eda-Cadenas I, Vazquez L, Lopez-Jimenez J, Chorao P, Aroca C, Garc\u00eda-Vidal C, Arroyo I, Soler-Espejo E, L\u00f3pez-Corral L, Avenda\u00f1o-Pita A, Arrufat A, Garcia-Gutierrez V, Arellano E, Hern\u00e1ndez-Medina L, Gonz\u00e1lez-Santillana C, Morell J, Hern\u00e1ndez-Rivas J, Rodriguez-Galvez P, Mico-Cerd\u00e1 M, Guerreiro M, Campos D, Navarro D, Cedillo A, Martino R, Solano C. Viruses. 2023 Oct 8;15(10):2066. doi: <a href='https:\/\/doi.org\/10.3390\/v15102066' target='_blank'>10.3390\/v15102066<\/a>. PMID: <a href='https:\/\/pubmed.ncbi.nlm.nih.gov\/37896843' target='_blank'>37896843<\/a><\/p>\n<p>Respiratory virus infections after allogeneic stem cell transplantation: Current understanding, knowledge gaps, and recent advances. Pinana J, Perez A, Chorao P, Guerreiro M, Garcia-Cadenas I, Solano C, Martino R, Navarro D. Transplant Infectious Disease. 2023 Nov:25 Suppl 1:e14117. doi: <a href='https:\/\/doi.org\/10.1111\/tid.14117' target='_blank'>10.1111\/tid.14117<\/a>. PMID: <a href='https:\/\/pubmed.ncbi.nlm.nih.gov\/37585370' target='_blank'>37585370<\/a><\/p>\n<p>Results of phase 2 randomized multi-center study to evaluate the safety and efficacy of infusion of memory T cells as adoptive therapy in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia and\/or lymphopenia (RELEASE NCT04578210). Ferreras C, Hern\u00e1ndez-Blanco C, Mart\u00edn-Quir\u00f3s A, Al-Akioui-Sanz K, Mora-Rillo M, Ib\u00e1\u00f1ez F, D\u00edaz-Almir\u00f3n M, Cano-Ochando J, Lozano-Ojalvo D, Jim\u00e9nez-Gonz\u00e1lez M, Goterris R, S\u00e1nchez-Zapardiel E, de Paz R, Guerra-Garc\u00eda P, Queiruga-Parada J, Molina P, Briones ML, Ruz-Caracuel B, Borobia AM, Carcas AJ, Planelles D, Vicario JL, Moreno M\u00c1, Balas A, Llano M, Llorente A, Del Balzo \u00c1, Ca\u00f1ada C, Garc\u00eda M\u00c1, Calvin ME, Arenas I, P\u00e9rez de Diego R, Eguiz\u00e1bal C, Soria B, Solano C, P\u00e9rez-Mart\u00ednez A. Cytotherapy. 2023 Oct 29:S1465-3249(23)01056-3. doi: <a href='https:\/\/doi.org\/10.1016\/j.jcyt.2023.10.002' target='_blank'>10.1016\/j.jcyt.2023.10.002<\/a>. PMID: <a href='https:\/\/pubmed.ncbi.nlm.nih.gov\/37897472' target='_blank'>37897472<\/a><\/p>\n<p>SARS-CoV-2-reactive antibody waning, booster effect and breakthrough SARS-CoV-2 infection in hematopoietic stem cell transplant and cell therapy recipients at one year after vaccination. Pinana J, Martino R, Vazquez L, Lopez-Corral L, Perez A, Chorao P, Avendano Pita A, Pascual M, Sanchez Salinas A, Sanz Linares G, Olave M, Arroyo I, Tormo M, Villalon L, Conesa Garcia V, Gago B, Terol M, Villalba M, Garcia Gutierrez V, Cabero A, Hernandez Rivas J, Ferrer E, Garcia Cadenas I, Teruel A, Navarro D, Cedillo A, Sureda A, Solano C. Bone Marrow Transplantation. 2023 Feb 28;1-14. doi: <a href='https:\/\/doi.org\/10.1038\/s41409-023-01946-0' target='_blank'>10.1038\/s41409-023-01946-0<\/a>. PMID: <a href='https:\/\/pubmed.ncbi.nlm.nih.gov\/36854892' target='_blank'>36854892<\/a><\/p>\n<p>Torque Teno Virus plasma DNA load: a novel prognostic biomarker in CAR-T therapy. Benzaqu\u00e9n A, Gim\u00e9nez E, Iacoboni G, Guerreiro M, Hernani R, Albert E, Carpio C, Balaguer A, P\u00e9rez A, S de la Asunci\u00f3n C, S\u00e1nchez-Salinas MA, Chor\u00e3o P, Pi\u00f1ana JL, Beas F, Montoro J, Hern\u00e1ndez-Boluda JC, Facal A, Ferrer B, Villalba M, Amat P, Gom\u00e9z MD, Campos D, Terol MJ, Sanz J, Barba P, Navarro D, Solano C. Bone Marrow Transplantation. 2023 Nov 2. doi: <a href='https:\/\/doi.org\/10.1038\/s41409-023-02114-0' target='_blank'>10.1038\/s41409-023-02114-0<\/a>. PMID: <a href='https:\/\/pubmed.ncbi.nlm.nih.gov\/37919456' target='_blank'>37919456<\/a><\/p>\n<p>Treatment for first cytomegalovirus infection post-hematopoietic cell transplant in the AURORA Trial: a multicenter, double-blind, randomized, phase 3 trial comparing maribavir with valganciclovir. Papanicolaou GA, Avery RK, Cordonnier C, Duarte RF, Haider S, Maertens J, Peggs KS, Solano C, Young JH, Fournier M, Murray RA, Wu J, Winston DJ; AURORA Trial Investigators. Clinical Infectious Diseases. 2023 Nov 30:ciad709. doi: <a href='https:\/\/doi.org\/10.1093\/cid\/ciad709' target='_blank'>10.1093\/cid\/ciad709<\/a>. PMID: <a href='https:\/\/pubmed.ncbi.nlm.nih.gov\/38036487' target='_blank'>38036487<\/a><\/p>\n<\/div><\/div><\/div>\n<\/div><\/div><\/div>\n<\/div><div class=\"nav fusion-mobile-tab-nav\"><ul class=\"nav-tabs nav-justified\"><li><a class=\"tab-link\" data-toggle=\"tab\" role=\"tab\" aria-controls=\"tab-da6675919f212aca7e7\" aria-selected=\"false\" tabindex=\"-1\" id=\"mobile-fusion-tab-2022\" href=\"#tab-da6675919f212aca7e7\"><h4 class=\"fusion-tab-heading\">2022<\/h4><\/a><\/li><\/ul><\/div><div class=\"tab-pane fade fusion-clearfix\" role=\"tabpanel\" tabindex=\"0\" aria-labelledby=\"fusion-tab-2022\" id=\"tab-da6675919f212aca7e7\">\n<div style=\"padding-top:4%;padding-left:4%; padding-right:4%; text-align:justify;\">\nAllogeneic stem cell transplantation in mantle cell lymphoma; insights into its potential role in the era of new immunotherapeutic and targeted therapies: the GETH\/GELTAMO experience. Gutierrez A, Bento L, Novelli S, Martin A, Gutierrez G, Salas M, Bastos-Oreiro M, Perez A, Hernani R, Viguria M, Lopez-Godino O, Montoro J, Pinana J, Ferra C, Parody R, Martin C, Espanol I, Yanez L, Rodriguez G, Zanabili J, Herrera P, Varela M, Sampol A, Solano C, Caballero D. Cancers. 2022 May 27;14(11):2673. doi: <a href='https:\/\/doi.org\/10.3390\/cancers14112673' target='_blank'>10.3390\/cancers14112673<\/a>. PMID: <a href='https:\/\/pubmed.ncbi.nlm.nih.gov\/35681653' target='_blank'>35681653<\/a><\/p>\n<p>Applicability of probabilistic graphical models for early detection of SARS-CoV-2 reactive antibodies after SARS-CoV-2 vaccination in hematological patients. Pinana J, Rodriguez-Belenguer P, Caballero D, Martino R, Lopez-Corral L, Terol M, Vazquez L, Calabuig M, Sanz-Linares G, Marin-Jimenez F, Alonso C, Montoro J, Ferrer E, Facal A, Pascual M, Rodriguez-Fernandez A, Olave M, Cascales-Hernandez A, Gago B, Hernandez-Rivas J, Villalon L, Corona M, Roldan-Perez A, Ribes-Amoros J, Gonzalez-Santillana C, Garcia-Sanz R, Navarro D, Serrano-Lopez A, Cedillo A, Soria-Olivas E, Sureda A, Solano C. Annals of Hematology. 2022 Sep;101(9):2053-2067. doi: <a href='https:\/\/doi.org\/10.1007\/s00277-022-04906-8' target='_blank'>10.1007\/s00277-022-04906-8<\/a>. PMID: <a href='https:\/\/pubmed.ncbi.nlm.nih.gov\/35780254' target='_blank'>35780254<\/a><\/p>\n<p>Booster effect after SARS-CoV-2 vaccination in immunocompromised hematology patients with prior COVID-19. Pi\u00f1ana JL, Garcia-Sanz R, Martino R, Garcia-Roa M, Martin-Martin GA, Risco-G\u00e1lvez I, Tormo M, Martinez-Barranco P, Marcos-Corrales S, Calabuig M, Conesa V, Teruel A, Ruiz-P\u00e9rez S, Solano C, Navarro D, Cedillo \u00c1, Sureda A. Blood Advances. 2022 Jan 8;6(3):848-853. doi: <a href='https:\/\/doi.org\/10.1182\/bloodadvances.2021006326' target='_blank'>10.1182\/bloodadvances.2021006326<\/a>. PMID: <a href='https:\/\/pubmed.ncbi.nlm.nih.gov\/34905620' target='_blank'>34905620<\/a><\/p>\n<p>Identifying SARS-CoV-2 &#8216;memory&#8217; NK cells from COVID-19 convalescent donors for adoptive cell therapy. Herrera L, Martin-Inaraja M, Santos S, Ingles-Ferrandiz M, Azkarate A, Perez-Vaquero MA, Vesga MA, Vicario JL, Soria B, Solano C, De Paz R, Marcos A, Ferreras C, Perez-Martinez A, Eguizabal C. Immunology. 2022 Feb;165(2):234-249. doi: <a href='https:\/\/doi.org\/10.1111\/imm.13432' target='_blank'>10.1111\/imm.13432<\/a>. doi: <a href='https:\/\/doi.org\/10.1111\/imm.13432' target='_blank'>10.1111\/imm.13432<\/a>. PMID: <a href='https:\/\/pubmed.ncbi.nlm.nih.gov\/34775592' target='_blank'>34775592<\/a><\/p>\n<p>Multi-body-site colonization screening cultures for predicting multi-drug resistant Gram-negative and Gram-positive bacteremia in hematological patients. Torres I, Huntley D, Tormo M, Calabuig M, Hernandez-Boluda J, Terol M, Carretero C, de Michelena P, Perez A, Pinana J, Colomina J, Solano C, Navarro D. BMC Infectious Diseases. 2022 Feb 21;22(1):172. doi: <a href='https:\/\/doi.org\/10.1186\/s12879-022-07154-3' target='_blank'>10.1186\/s12879-022-07154-3<\/a>. PMID: <a href='https:\/\/pubmed.ncbi.nlm.nih.gov\/35189833' target='_blank'>35189833<\/a><\/p>\n<style type=\"text\/css\">.fusion-accordian  #accordion-7534-2 .panel-title a .fa-fusion-box{ color: #ffffff;}.fusion-accordian  #accordion-7534-2 .panel-title a .fa-fusion-box:before{ font-size: 14px; width: 14px;}.fusion-accordian  #accordion-7534-2.fusion-toggle-icon-right .fusion-toggle-heading{ margin-right: 32px;}.fusion-accordian  #accordion-7534-2 .panel-title a{font-size:14px;}.fusion-accordian  #accordion-7534-2 .fa-fusion-box { background-color: #212934;border-color: #212934;}.fusion-accordian  #accordion-7534-2 .panel-title a:hover, #accordion-7534-2 .fusion-toggle-boxed-mode:hover .panel-title a { color: #3bafbf;}.fusion-accordian  #accordion-7534-2 .panel-title .active .fa-fusion-box,.fusion-accordian  #accordion-7534-2 .panel-title a:hover .fa-fusion-box { background-color: #3bafbf!important;border-color: #3bafbf!important;}<\/style><div class=\"accordian fusion-accordian\"><div class=\"panel-group fusion-toggle-icon-right\" id=\"accordion-7534-2\" role=\"tablist\">\n<div class=\"fusion-panel panel-default\" role=\"tabpanel\"><div class=\"panel-heading\"><h4 class=\"panel-title toggle\"><a aria-expanded=\"false\" aria-selected=\"false\" aria-controls=\"ab2cc96de90ec0a33\" role=\"tab\" data-toggle=\"collapse\" data-parent=\"#accordion-7534-2\" data-target=\"#ab2cc96de90ec0a33\" href=\"#ab2cc96de90ec0a33\"><span class=\"fusion-toggle-icon-wrapper\" aria-hidden=\"true\"><i class=\"fa-fusion-box\" aria-hidden=\"true\"><\/i><\/span><span class=\"fusion-toggle-heading\">More publications from 2022<\/span><\/a><\/h4><\/div><div id=\"ab2cc96de90ec0a33\" class=\"panel-collapse collapse \"><div class=\"panel-body toggle-content fusion-clearfix\">\nPost-transplant cyclophosphamide after HLA identical compared to Haploidentical donor transplant in Acute Myeloid Leukemia: a study on behalf of GETH-TC. Bailen R, Pascual-Cascon M, Guerreiro M, Lopez-Corral L, Chinea A, Bermudez A, Sampol A, Heras I, Garcia-Torres E, Torres M, Roca J, Herruzo B, Sanz J, Fonseca M, Herrera P, Colorado M, Bento L, Lopez-Godino O, Martin-Calvo C, Fernandez-Caldas P, Marcos-Jubilar M, Sanchez-Ortega I, Solano C, Noriega V, Humala K, Oarbeascoa G, Jose Luis Diez-Martin J, Kwon M, Grupo Espanol de Trasplante Hematopoyetico y Terapia Celular (GETH). Transplantation and Cellular Therapy. 2022 Apr;28(4):204.e1-204.e10. doi: <a href='https:\/\/doi.org\/10.1016\/j.jtct.2022.01.020' target='_blank'>10.1016\/j.jtct.2022.01.020<\/a>. PMID: <a href='https:\/\/pubmed.ncbi.nlm.nih.gov\/35108627' target='_blank'>35108627<\/a><\/p>\n<p>Post-transplant cyclophosphamide and sirolimus based graft-versus-host disease prophylaxis after allogeneic stem cell transplantation for acute myeloid leukemia. Lazzari L, Balaguer-Rosello A, Montoro J, Greco R, Hernani R, Lupo-Stanghellini M, Villalba M, Giglio F, Facal A, Lorentino F, Guerreiro M, Bruno A, Perez A, Xue E, Clerici D, Piemontese S, Pinana J, Sanz M, Solano C, de la Rubia J, Ciceri F, Peccatori J, Sanz J. Bone Marrow Transplantation. 2022 Sep;57(9):1389-1398. doi: <a href='https:\/\/doi.org\/10.1038\/s41409-022-01725-3' target='_blank'>10.1038\/s41409-022-01725-3<\/a>. PMID: <a href='https:\/\/pubmed.ncbi.nlm.nih.gov\/35680995' target='_blank'>35680995<\/a><\/p>\n<p>SARS-CoV-2 vaccine response and rate of breakthrough infection in patients with hematological disorders. Pinana JL, Lopez-Corral L, Martino R, Vazquez L, Perez A, Martin-Martin G, Gago B, Sanz-Linares G, Sanchez-Salinas A, Villalon L, Conesa-Garcia V, Olave MT, Corona M, Marcos-Corrales S, Tormo M, Hernandez-Rivas JA, Montoro J, Rodriguez-Fernandez A, Risco-Galvez I, Rodriguez-Belenguer P, Hernandez-Boluda JC, Garcia-Cadenas I, Ruiz-Garcia M, Munoz-Bellido JL, Solano C, Cedillo A, Sureda A, Navarro D. Journal of Hematology &#038; Oncology. 2022 May 7;15(1):54. doi: <a href='https:\/\/doi.org\/10.1186\/s13045-022-01275-7' target='_blank'>10.1186\/s13045-022-01275-7<\/a>. PMID: <a href='https:\/\/pubmed.ncbi.nlm.nih.gov\/35526045' target='_blank'>35526045<\/a><\/p>\n<p>SARS-CoV-2-reactive antibody detection after SARS-CoV-2 vaccination in hematopoietic stem cell transplant recipients: Prospective survey from the Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group (GETH-TC). Pinana J, Lopez-Corral L, Martino R, Montoro J, Vazquez L, Perez A, Martin-Martin G, Facal-Malvar A, Ferrer E, Pascual M, Sanz-Linares G, Gago B, Sanchez-Salinas A, Villalon L, Conesa-Garcia V, Olave M, Lopez-Jimenez J, Marcos-Corrales S, Garcia-Blazquez M, Garcia-Gutierrez V, Hernandez-Rivas J, Saus A, Espigado I, Alonso C, Hernani R, Solano C, Ferrer-Lores B, Guerreiro M, Ruiz-Garcia M, Munoz-Bellido J, Navarro D, Cedillo A, Sureda A, Infectious Complications Subcommittee of the Spanish Hematopoietic Stem, Cell Transplantation and Cell Therapy Group (GETH-TC). American Journal of Hematology. 2022 Jan 1;97(1):30-42. doi: <a href='https:\/\/doi.org\/10.1002\/ajh.26385' target='_blank'>10.1002\/ajh.26385<\/a>. PMID: <a href='https:\/\/pubmed.ncbi.nlm.nih.gov\/34695229' target='_blank'>34695229<\/a><\/p>\n<p>Toxicities following CAR-T therapy for hematological malignancies. Hernani R, Benzaquen A, Solano C. Cancer Treatment Reviews. 2022 Dec;111:102479. doi: <a href='https:\/\/doi.org\/10.1016\/j.ctrv.2022.102479' target='_blank'>10.1016\/j.ctrv.2022.102479<\/a>. PMID: <a href='https:\/\/pubmed.ncbi.nlm.nih.gov\/36308910' target='_blank'>36308910<\/a><\/p>\n<\/div><\/div><\/div>\n<\/div><\/div><\/div>\n<\/div><div class=\"nav fusion-mobile-tab-nav\"><ul class=\"nav-tabs nav-justified\"><li><a class=\"tab-link\" data-toggle=\"tab\" role=\"tab\" aria-controls=\"tab-73e62403f21662cb1a5\" aria-selected=\"false\" tabindex=\"-1\" id=\"mobile-fusion-tab-2021\" href=\"#tab-73e62403f21662cb1a5\"><h4 class=\"fusion-tab-heading\">2021<\/h4><\/a><\/li><\/ul><\/div><div class=\"tab-pane fade fusion-clearfix\" role=\"tabpanel\" tabindex=\"0\" aria-labelledby=\"fusion-tab-2021\" id=\"tab-73e62403f21662cb1a5\">\n<div style=\"padding-top:4%;padding-left:4%; padding-right:4%; text-align:justify;\">\nA phase I\/II dose-escalation multi-center study to evaluate the safety of infusion  of natural killer cells or memory T cells as adoptive therapy in coronavirus  pneumonia and\/or lymphopenia: RELEASE study protocol. Garc\u00eda-Garc\u00eda I, Guerra-Garc\u00eda P, Ferreras C, Borobia A, Carcas A, Queiruga-Parada J, Vicario J, Mirones I, Solano Vercet C, Eguizabal C, Soria B, P\u00e9rez-Mart\u00ednez A. Trials. 2021 Oct 2;22(1):674. doi: <a href='https:\/\/doi.org\/10.1186\/s13063-021-05625-7' target='_blank'>10.1186\/s13063-021-05625-7<\/a>. PMID: <a href='https:\/\/pubmed.ncbi.nlm.nih.gov\/34600562' target='_blank'>34600562<\/a><\/p>\n<p>Addition of rituximab in reduced intensity conditioning regimens for B-Cell malignancies does not influence transplant outcomes: EBMT registry analyses following allogeneic stem cell transplantation for B-Cell malignancies. Tomaszewska A, Jagasia M, Beohou E, van der Werf S, Blaise D, Kanfer E, Milpied N, Remenyi P, Ciceri F, Bourhis J, Chevallier P, Solano C, Socie G, Bruno B, Rambaldi A, Castagna L, Kroger N, Corradini P, Afanasyev B, Ladetto M, Niederwieser D, Scheid C, Sengeloev H, Kroschinsky F, Yakoub-Agha I, Schoemans H, Koenecke C, Penack O, Peric Z, Greinix H, Duarte R, Basak G. Frontiers in Immunology. 2021 Feb 2;11:613954. doi: <a href='https:\/\/doi.org\/10.3389\/fimmu.2020.613954' target='_blank'>10.3389\/fimmu.2020.613954<\/a>. PMID: <a href='https:\/\/pubmed.ncbi.nlm.nih.gov\/33603743' target='_blank'>33603743<\/a><\/p>\n<p>Allogeneic Hematopoietic Stem Cell Transplant recipients in Spain: Human Leucocyte Antigen characteristics and diversity by high-resolution analysis. Guerreiro M, Planelles D, Aguilar-Gallardo C, Lorenzo J, Montoro J, Sanz J, Balaguer A, Gomez I, Solves P, Perez A, Blanquer M, Espigado I, Solano C, Pinana J, Grupo Espanol de Trasplante Hematopoyetico y Terapia Celular (GETH). HLA. 2021 Mar;97(3):198-213. doi: <a href='https:\/\/doi.org\/10.1111\/tan.14179' target='_blank'>10.1111\/tan.14179<\/a>. PMID: <a href='https:\/\/pubmed.ncbi.nlm.nih.gov\/33369244' target='_blank'>33369244<\/a><\/p>\n<p>Amplification of human beta-glucoronidase gene for appraising the accuracy of negative SARS-CoV-2 RT-PCR results in upper respiratory tract specimens. Albert Vicent E, Ferrer Lores B, Torres Fink I, Serrano Alcal\u00e1 A, Alcar\u00e1z Soriana M, Buesa Gomez J, Solano Vercet C, Colomina Rodr\u00edguez F, Bueno Ferrando F, Huntley Pascual D, Olea Miguel B, Valdivia Piqueres A, Navarro Ortega D. Journal of Medical Virology. 2021 Jan;93(1):48-50. doi: <a href='https:\/\/doi.org\/10.1002\/jmv.26112' target='_blank'>10.1002\/jmv.26112<\/a>. PMID: <a href='https:\/\/pubmed.ncbi.nlm.nih.gov\/32484950' target='_blank'>32484950<\/a><\/p>\n<p>An investigation of the potential association between gastrointestinal viral and bacterial infection and development of intestinal acute graft versus host disease following allogeneic hematopoietic stem cell transplantation. Bueno F, Albert E, Gimenez E, Pinana J, Perez A, Gomez M, Hernandez-Boluda J, Gonzalez-Barbera E, Montoro J, Buesa J, Guerreiro M, Balaguer-Rosello A, Hernani R, Sanz J, Solano C, Navarro D. Journal of Medical Virology. 2021 Aug;93(8):4773-4779. doi: <a href='https:\/\/doi.org\/10.1002\/jmv.26892' target='_blank'>10.1002\/jmv.26892<\/a>. PMID: <a href='https:\/\/pubmed.ncbi.nlm.nih.gov\/33605457' target='_blank'>33605457<\/a><\/p>\n<style type=\"text\/css\">.fusion-accordian  #accordion-7534-3 .panel-title a .fa-fusion-box{ color: #ffffff;}.fusion-accordian  #accordion-7534-3 .panel-title a .fa-fusion-box:before{ font-size: 14px; width: 14px;}.fusion-accordian  #accordion-7534-3.fusion-toggle-icon-right .fusion-toggle-heading{ margin-right: 32px;}.fusion-accordian  #accordion-7534-3 .panel-title a{font-size:14px;}.fusion-accordian  #accordion-7534-3 .fa-fusion-box { background-color: #212934;border-color: #212934;}.fusion-accordian  #accordion-7534-3 .panel-title a:hover, #accordion-7534-3 .fusion-toggle-boxed-mode:hover .panel-title a { color: #3bafbf;}.fusion-accordian  #accordion-7534-3 .panel-title .active .fa-fusion-box,.fusion-accordian  #accordion-7534-3 .panel-title a:hover .fa-fusion-box { background-color: #3bafbf!important;border-color: #3bafbf!important;}<\/style><div class=\"accordian fusion-accordian\"><div class=\"panel-group fusion-toggle-icon-right\" id=\"accordion-7534-3\" role=\"tablist\">\n<div class=\"fusion-panel panel-default\" role=\"tabpanel\"><div class=\"panel-heading\"><h4 class=\"panel-title toggle\"><a aria-expanded=\"false\" aria-selected=\"false\" aria-controls=\"d53ae26be6d02bdde\" role=\"tab\" data-toggle=\"collapse\" data-parent=\"#accordion-7534-3\" data-target=\"#d53ae26be6d02bdde\" href=\"#d53ae26be6d02bdde\"><span class=\"fusion-toggle-icon-wrapper\" aria-hidden=\"true\"><i class=\"fa-fusion-box\" aria-hidden=\"true\"><\/i><\/span><span class=\"fusion-toggle-heading\">More publications from 2021<\/span><\/a><\/h4><\/div><div id=\"d53ae26be6d02bdde\" class=\"panel-collapse collapse \"><div class=\"panel-body toggle-content fusion-clearfix\">\nBiomarker profile predicts clinical efficacy of extracorporeal photopheresis in steroid-resistant acute and chronic graft-vs-host disease after allogenic hematopoietic stem cell transplant. Amat P, Lopez-Corral L, Goterris R, Perez A, Lopez O, Heras I, Arbona C, Viguria MC, Hernandez-Boluda JC, Martinez-Ruiz F, Martinez A, Solano C. Journal of Clinical Apheresis. 2021 Oct;36(5):697-710. doi: <a href='https:\/\/doi.org\/10.1002\/jca.21918' target='_blank'>10.1002\/jca.21918<\/a>. PMID: <a href='https:\/\/pubmed.ncbi.nlm.nih.gov\/34185332' target='_blank'>34185332<\/a><\/p>\n<p>CAR-T therapy in solid transplant recipients with post-transplant lymphoproliferative disease: case report and literature review. Hernani R, Sancho A, Amat P, Hernandez-Boluda J, Perez A, Pinana J, Carretero C, Goterris R, Gomez M, Saus A, Ferrer B, Teruel A, Terol M, Solano C. Current Research in Translational Medicine. 2021 Jul 22;69(4):103304. doi: <a href='https:\/\/doi.org\/10.1016\/j.retram.2021.103304' target='_blank'>10.1016\/j.retram.2021.103304<\/a>. PMID: <a href='https:\/\/pubmed.ncbi.nlm.nih.gov\/34303899' target='_blank'>34303899<\/a><\/p>\n<p>Clinical outcomes of allogeneic hematopoietic stem cell transplant recipients developing Cytomegalovirus DNAemia prior to engraftment. Solano C, Vazquez L, Gimenez E, de la Camara R, Albert E, Rovira M, Espigado I, Calvo C, Lopez-Jimenez J, Suarez-Lledo M, Chinea A, Esquirol A, Perez A, Bermudez A, Saldana R, Heras I, Gonzalez-Huerta A, Torrado T, Batlle M, Jimenez S, Vallejo C, Barba P, Cuesta M, Pinana J, Navarro D, Spanish Group of Hematopoietic Transplantation and Cell Therapy (GETH). Bone Marrow Transplantation. 2021 Jun;56(6):1281-1290. doi: <a href='https:\/\/doi.org\/10.1038\/s41409-020-01157-x' target='_blank'>10.1038\/s41409-020-01157-x<\/a>. PMID: <a href='https:\/\/pubmed.ncbi.nlm.nih.gov\/33319853' target='_blank'>33319853<\/a><\/p>\n<p>Cytomegalovirus DNAemia and risk of mortality in allogeneic hematopoietic stem cell transplantation: Analysis from the Spanish Hematopoietic Transplantation and Cell Therapy Group. Solano Vercet C, Vazquez L, Gimenez Quiles E, De La Camara R, Albert Vicent E, Rovira M, Espigado I, Calvo C, Lopez-Jimenez J, Suarez-Lledo M, Chinea A, Esquirol A, Perez Martinez A, Bermudez A, Saldana R, Heras I, Gonzalez-Huerta A, Torrado T, Bautista G, Batlle M, Jimenez S, Vallejo C, Barba P, Cuesta M, Pinana J, Navarro Ortega D. American Journal of Transplantation. 2021 Jan;21(1):258-271. doi: <a href='https:\/\/doi.org\/10.1111\/ajt.16147' target='_blank'>10.1111\/ajt.16147<\/a>. PMID: <a href='https:\/\/pubmed.ncbi.nlm.nih.gov\/32812351' target='_blank'>32812351<\/a><\/p>\n<p>Cytomegalovirus-specific T-cell immunity and DNAemia in patients with chronic lymphocytic leukaemia undergoing treatment with ibrutinib. De la Asuncion C, Terol M, Saus A, Olea B, Gimenez E, Albert E, Lopez-Jimenez J, Andreu R, Garcia D, Fox L, Remigia M, Amat P, Solano C, Navarro D. British Journal of Haematology. 2021 Nov;195(4):637-641. doi: <a href='https:\/\/doi.org\/10.1111\/bjh.17732' target='_blank'>10.1111\/bjh.17732<\/a>. PMID: <a href='https:\/\/pubmed.ncbi.nlm.nih.gov\/34402042' target='_blank'>34402042<\/a><\/p>\n<p>Diversity and dynamic changes of Anelloviruses in plasma following Allogeneic Hematopoietic Stem Cell Transplantation. Gimenez Quiles E, Monzo Catalu\u00f1a C, Albert Vicent E, Fuentes Trillo A, Seda Garc\u00eda E, Pinana J, Hernandez Boluda J, Solano Vercet C, Chaves Mart\u00ednez F, Navarro Ortega D. Journal of Medical Virology. 2021 Aug;93(8):5167-5172. doi: <a href='https:\/\/doi.org\/10.1002\/jmv.26661' target='_blank'>10.1002\/jmv.26661<\/a>. PMID: <a href='https:\/\/pubmed.ncbi.nlm.nih.gov\/33174620' target='_blank'>33174620<\/a><\/p>\n<p>Hospital and outpatient models for Hematopoietic Stem Cell Transplantation: a systematic review of comparative studies for health outcomes, experience of care and costs. Gonzalez M, Urizar E, Urtaran-Laresgoiti M, Nuno-Solinis R, Lazaro-Perez E, Vazquez L, Pascual-Cascon M, Solano C, Kwon M, Gallego C, Fernandez-Aviles F. PLoS One. 2021 Aug 12;16(8):e0254135. doi: <a href='https:\/\/doi.org\/10.1371\/journal.pone.0254135' target='_blank'>10.1371\/journal.pone.0254135<\/a>. PMID: <a href='https:\/\/pubmed.ncbi.nlm.nih.gov\/34383780' target='_blank'>34383780<\/a><\/p>\n<p>Myelodysplastic syndromes with 20q deletion: incidence, prognostic value and impact on response to azacitidine of ASXL1 chromosomal deletion and genetic mutations. Martin I, Villamon E, Abellan R, Calasanz M, Irigoyen A, Sanz G, Such E, Mora E, Gutierrez M, Collado R, Garcia-Serra R, Vara M, Blanco M, Oiartzabal I, Alvarez S, Bernal T, Granada I, Xicoy B, Jerez A, Calabuig M, Diez R, Gil A, Diez-Campelo M, Solano C, Tormo M, Spanish Grp Myelodysplastic Syn. British Journal of Haematology. 2021 Aug;194(4):708-717. doi: <a href='https:\/\/doi.org\/10.1111\/bjh.17675' target='_blank'>10.1111\/bjh.17675<\/a>. PMID: <a href='https:\/\/pubmed.ncbi.nlm.nih.gov\/34296432' target='_blank'>34296432<\/a><\/p>\n<p>Real-world evidence of tisagenlecleucel for the treatment of relapsed or refractory large B-cell lymphoma. Cancer medicine. Iacoboni G, Villacampa G, Martinez-Cibrian N, Bailen R, Lopez Corral L, Sanchez J, Guerreiro M, Caballero A, Mussetti A, Sancho J, Hernani Morales R, Abrisqueta P, Solano Vercet C, Sureda A, Briones J, Martin Garcia-Sancho A, Kwon M, Reguera-Ortega J, Barba P, GETH G. 2021 May;10(10):3214-3223. doi: <a href='https:\/\/doi.org\/10.1002\/cam4.3881' target='_blank'>10.1002\/cam4.3881<\/a>. PMID: <a href='https:\/\/pubmed.ncbi.nlm.nih.gov\/33932100' target='_blank'>33932100<\/a><\/p>\n<p>SARS-CoV-2-reactive interferon-gamma-producing CD8+ T cells in patients hospitalized with Coronavirus Disease 2019. Gimenez Quiles E, Albert Vicent E, Torres Fink I, Remigia Pellicer M, Alcar\u00e1z Soriana M, Galindo Puerto M, Blasco Cortes M, Solano Vercet C, Forner Giner M, Red\u00f3n Mas J, Signes-Costa Mi\u00f1ana J, Navarro Ortega D. Journal of Medical Virology. 2021 Jan;93(1):375-382. doi: <a href='https:\/\/doi.org\/10.1002\/jmv.26213' target='_blank'>10.1002\/jmv.26213<\/a>. PMID: <a href='https:\/\/pubmed.ncbi.nlm.nih.gov\/32579268' target='_blank'>32579268<\/a><\/p>\n<p>SARS-CoV-2-specific memory t lymphocytes from COVID-19 convalescent donors: identification, biobanking, and large-scale production for adoptive cell therapy. Ferreras C, Pascual-Miguel B, Mestre-Duran C, Navarro-Zapata A, Clares-Villa L, Martin-Cortazar C, De Paz R, Marcos A, Vicario J, Balas A, Garcia-Sanchez F, Eguizabal C, Solano C, Mora-Rillo M, Soria B, Perez-Martinez A. Frontiers in Cell and Developmental Biology. 2021 Feb 25;9:620730. doi: <a href='https:\/\/doi.org\/10.3389\/fcell.2021.620730' target='_blank'>10.3389\/fcell.2021.620730<\/a>. PMID: <a href='https:\/\/pubmed.ncbi.nlm.nih.gov\/33718360' target='_blank'>33718360<\/a><\/p>\n<p>Seasonal human coronaviruses respiratory tract infection in recipients of allogeneic hematopoietic stem cell transplantation. Pinana J, Xhaard A, Tridello G, Passweg J, Kozijn A, Polverelli N, Heras I, Perez A, Sanz J, Berghuis D, Vazquez L, Suarez-Lledo M, Itala-Remes M, Ozcelik T, Iturrate Basaran I, Karakukcu M, Al Zahrani M, Choi G, Cuesta Casas M, Batlle Massana M, Viviana A, Blijlevens N, Ganser A, Kuskonmaz B, Labussiere-Wallet H, Shaw P, Arzu Yegin Z, Gonzalez-Vicent M, Rocha V, Ferster A, Knelange N, Navarro D, Mikulska M, de la Camara R, Styczynski J, Infectious Diseases Working Party of the European Society for Blood and, Marrow Transplantation and Infectious Complications Subcommittee of the, Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group, (GETH). The Journal of Infectious Diseases. 2021 May 20;223(9):1564-1575. doi: <a href='https:\/\/doi.org\/10.1093\/infdis\/jiaa553' target='_blank'>10.1093\/infdis\/jiaa553<\/a>. PMID: <a href='https:\/\/pubmed.ncbi.nlm.nih.gov\/32860509' target='_blank'>32860509<\/a><\/p>\n<p>Use of letermovir in off-label indications: Infectious Diseases Working Party of European Society of Blood and Marrow Transplantation retrospective study. Styczynski J, Tridello G, Xhaard A, Medinger M, Mielke S, Taskinen M, Blijlevens N, Rodriguez M, Solano C, Nikolousis E, Biffi A, Groll A, Junghanss C, Tsirigotis P, Lioure B, Sramek J, Holler E, Galaverna F, Fagioli F, Knelange N, Wendel L, Gil L, de la Camara R, Mikulska M, Ljungman P. Bone Marrow Transplantation. 2021 May;56(5):1171-1179. doi: <a href='https:\/\/doi.org\/10.1038\/s41409-020-01166-w' target='_blank'>10.1038\/s41409-020-01166-w<\/a>. PMID: <a href='https:\/\/pubmed.ncbi.nlm.nih.gov\/33288863' target='_blank'>33288863<\/a><\/p>\n<\/div><\/div><\/div>\n<\/div><\/div><\/div>\n<\/div><\/div><\/div>\n<\/div><\/div><style type=\"text\/css\">.fusion-body .fusion-builder-column-2{width:100% !important;margin-top : 0px;margin-bottom : 20px;}.fusion-builder-column-2 > .fusion-column-wrapper {padding-top : 0px !important;padding-right : 0px !important;margin-right : 1.92%;padding-bottom : 0px !important;padding-left : 0px !important;margin-left : 1.92%;}@media only screen and (max-width:1532px) {.fusion-body .fusion-builder-column-2{width:100% !important;}.fusion-builder-column-2 > .fusion-column-wrapper {margin-right : 1.92%;margin-left : 1.92%;}}@media only screen and (max-width:640px) {.fusion-body .fusion-builder-column-2{width:100% !important;}.fusion-builder-column-2 > .fusion-column-wrapper {margin-right : 1.92%;margin-left : 1.92%;}}<\/style>\n<\/div>\n<style type=\"text\/css\">.fusion-body .fusion-flex-container.fusion-builder-row-2{ padding-top : 2%;margin-top : 0px;padding-right : 0px;padding-bottom : 0px;margin-bottom : 0px;padding-left : 0px;}<\/style><\/div><div class=\"fusion-fullwidth fullwidth-box fusion-builder-row-3 fusion-flex-container nonhundred-percent-fullwidth non-hundred-percent-height-scrolling\" style=\"background-color: #9da0d2;background-position: center center;background-repeat: no-repeat;border-width: 0px 0px 0px 0px;border-color:#e2e2e2;border-style:solid;\" ><div class=\"fusion-builder-row fusion-row fusion-flex-align-items-flex-start\" style=\"max-width:1248px;margin-left: calc(-4% \/ 2 );margin-right: calc(-4% \/ 2 );\">\n<div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-3 fusion_builder_column_1_1 1_1 fusion-flex-column\"><div class=\"fusion-column-wrapper fusion-flex-justify-content-flex-start fusion-content-layout-column\" style=\"background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;padding: 0px 0px 0px 0px;\">\n<div class=\"fusion-text fusion-text-6\" style=\"transform:translate3d(0,0,0);\"><h5 style=\"text-align: left;\">Projects<\/h5>\n<\/div>\n<div class=\"fusion-tabs fusion-tabs-2 classic horizontal-tabs icon-position-left\"><style type=\"text\/css\">.fusion-tabs.fusion-tabs-2 .nav-tabs li a.tab-link{border-top-color:#f9f9fb;background-color:#f9f9fb;}.fusion-tabs.fusion-tabs-2 .nav-tabs{background-color:#ffffff;}.fusion-tabs.fusion-tabs-2 .nav-tabs li.active a.tab-link,.fusion-tabs.fusion-tabs-2 .nav-tabs li.active a.tab-link:hover,.fusion-tabs.fusion-tabs-2 .nav-tabs li.active a.tab-link:focus{border-right-color:#ffffff;}.fusion-tabs.fusion-tabs-2 .nav-tabs li.active a.tab-link,.fusion-tabs.fusion-tabs-2 .nav-tabs li.active a.tab-link:hover,.fusion-tabs.fusion-tabs-2 .nav-tabs li.active a.tab-link:focus{background-color:#ffffff;}.fusion-tabs.fusion-tabs-2 .nav-tabs li a:hover{background-color:#ffffff;border-top-color:#ffffff;}.fusion-tabs.fusion-tabs-2 .tab-pane{background-color:#ffffff;}.fusion-tabs.fusion-tabs-2 .nav,.fusion-tabs.fusion-tabs-2 .nav-tabs,.fusion-tabs.fusion-tabs-2 .tab-content .tab-pane{border-color:#e2e2e2;}<\/style><div class=\"nav\"><ul class=\"nav-tabs nav-justified\" role=\"tablist\"><li class=\"active\"><a class=\"tab-link\" data-toggle=\"tab\" role=\"tab\" aria-controls=\"tab-b9b1cc55260191d00ce\" aria-selected=\"true\" id=\"fusion-tab-projects\" href=\"#tab-b9b1cc55260191d00ce\"><h4 class=\"fusion-tab-heading\">PROJECTS<\/h4><\/a><\/li><\/ul><\/div><div class=\"tab-content\"><div class=\"nav fusion-mobile-tab-nav\"><ul class=\"nav-tabs nav-justified\"><li class=\"active\"><a class=\"tab-link\" data-toggle=\"tab\" role=\"tab\" aria-controls=\"tab-b9b1cc55260191d00ce\" aria-selected=\"true\" id=\"mobile-fusion-tab-projects\" href=\"#tab-b9b1cc55260191d00ce\"><h4 class=\"fusion-tab-heading\">PROJECTS<\/h4><\/a><\/li><\/ul><\/div><div class=\"tab-pane fade fusion-clearfix in active\" role=\"tabpanel\" tabindex=\"0\" aria-labelledby=\"fusion-tab-projects\" id=\"tab-b9b1cc55260191d00ce\">\n<div style=\"padding-top:4%;padding-left:4%; padding-right:4%; text-align:left;\">\n<div style=\"margin-bottom:40px;\">\n<span style=\"color:#3D44AC; font-size:16px;\">Reference: <\/span>PI21\/01628<br \/>\n<span style=\"color:#3D44AC; font-size:16px;\">Title: <\/span>Inmunobiolog\u00eda de c\u00e9lulas NK expandidas con criterios GMP de donantes seleccionados de banco de linfocitos para inmunoterapia adoptiva despu\u00e9s de TPH alog\u00e9nico o trasplante de \u00f3rgano s\u00f3lido<br \/>\n<span style=\"color:#3D44AC; font-size:16px;\">Funding body: <\/span>Instituto de Salud Carlos III &#8211; Cofinanciado FEDER<br \/>\n<span style=\"color:#3D44AC; font-size:16px;\">Principal Investigator: <\/span>Carlos Solano Vercet<br \/>\n<span style=\"color:#3D44AC; font-size:16px;\">Duration: <\/span>2022 &#8211; 2024<br \/>\n<span style=\"color:#3D44AC; font-size:16px;\">Total budget: <\/span>102.850 \u20ac\n<\/div>\n<div style=\"margin-bottom:40px;\">\n<span style=\"color:#3D44AC; font-size:16px;\">Reference: <\/span>BIO21\/COV\/030<br \/>\n<span style=\"color:#3D44AC; font-size:16px;\">Title: <\/span>Estudio de la inmunidad y Creaci\u00f3n de un Banco Nacional de Terapia Celular Adoptiva de donantes de linfocitos que han superado COVID-19. Ensayo cl\u00ednico Fase I multic\u00e9ntrico para evaluar la seguridad de la infusi\u00f3n de c\u00e9lulas natural killer como terapia adoptiva en casos pacientes con neumon\u00eda y\/o linfopenia debido al coronavirus SARS-CoV-2 (RELEASE)<br \/>\n<span style=\"color:#3D44AC; font-size:16px;\">Funding body: <\/span>Fundaci\u00f3n Vasca de Innovaci\u00f3n e investigaci\u00f3n Sanitarias (BIOEFF)<br \/>\n<span style=\"color:#3D44AC; font-size:16px;\">Principal Investigator: <\/span>Cristina Eguizabal<br \/>\n<span style=\"color:#3D44AC; font-size:16px;\">Duration: <\/span>2021 &#8211; 2022<br \/>\n<span style=\"color:#3D44AC; font-size:16px;\">Total budget: <\/span>99.935 \u20ac\n<\/div>\n<div style=\"margin-bottom:40px;\">\n<span style=\"color:#3D44AC; font-size:16px;\">Reference: <\/span>GV\/2020\/188<br \/>\n<span style=\"color:#3D44AC; font-size:16px;\">Title: <\/span>Anellovirus y Pegivirus un posible marcador del estado neto de inmunosupresi\u00f3n: evaluaci\u00f3n en el trasplante alog\u00e9nico de progenitores hematopoy\u00e9ticos<br \/>\n<span style=\"color:#3D44AC; font-size:16px;\">Funding body: <\/span>Conselleria de Educaci\u00f3n, Cultura y Deporte<br \/>\n<span style=\"color:#3D44AC; font-size:16px;\">Principal Investigator: <\/span>Estela Gim\u00e9nez Quiles<br \/>\n<span style=\"color:#3D44AC; font-size:16px;\">Duration: <\/span>2020 &#8211; 2021<br \/>\n<span style=\"color:#3D44AC; font-size:16px;\">Total budget: <\/span>16.000 \u20ac\n<\/div>\n<div style=\"margin-bottom:40px;\">\n<span style=\"color:#3D44AC; font-size:16px;\">Reference: <\/span>AP178182020<br \/>\n<span style=\"color:#3D44AC; font-size:16px;\">Title: <\/span>Estudio de la inmunidad y Creaci\u00f3n de un Banco Nacional de Terapia Celular Adoptiva de donantes de linfocitos que han superado COVID-19. Ensayo cl\u00ednico Fase I multic\u00e9ntrico para evaluar la seguridad de la infusi\u00f3n de c\u00e9lulas natural killer como terapia adoptiva en casos pacientes con neumon\u00eda y\/o linfopenia debido al coronavirus SARS-CoV-2 (RELEASE)<br \/>\n<span style=\"color:#3D44AC; font-size:16px;\">Funding body: <\/span>Fundaci\u00f3n Mutua Madrile\u00f1a<br \/>\n<span style=\"color:#3D44AC; font-size:16px;\">Principal Investigator: <\/span>Cristina Eguizabal<br \/>\n<span style=\"color:#3D44AC; font-size:16px;\">Duration: <\/span>2020 &#8211; 2021<br \/>\n<span style=\"color:#3D44AC; font-size:16px;\">Total budget: <\/span>100.000 \u20ac\n<\/div>\n<div style=\"margin-bottom:40px;\">\n<span style=\"color:#3D44AC; font-size:16px;\">Reference: <\/span>PI18\/01473<br \/>\n<span style=\"color:#3D44AC; font-size:16px;\">Title: <\/span>Inmunolog\u00eda de la infusi\u00f3n de linfocitos del donante con depleci\u00f3n ex vivo de linfocitos t cd45ra+ en pacientes con alto riesgo de infecci\u00f3n viral tras TPH alog\u00e9nico<br \/>\n<span style=\"color:#3D44AC; font-size:16px;\">Funding body: <\/span>Instituto de Salud Carlos III &#8211; Cofinanciado FEDER<br \/>\n<span style=\"color:#3D44AC; font-size:16px;\">Principal Investigator: <\/span>Carlos Solano Vercet<br \/>\n<span style=\"color:#3D44AC; font-size:16px;\">Duration: <\/span>2019 &#8211; 2023<br \/>\n<span style=\"color:#3D44AC; font-size:16px;\">Total budget: <\/span>123.420 \u20ac\n<\/div>\n<div style=\"margin-bottom:40px;\">\n<span style=\"color:#3D44AC; font-size:16px;\">Reference: <\/span>PI15\/01396<br \/>\n<span style=\"color:#3D44AC; font-size:16px;\">Title: <\/span>Inmunobiolog\u00eda de la aloreactividad NK en el trasplante de progenitores hematopoy\u00e9ticos haploidenticos asociado al uso de ciclofosfamida post-trasplante<br \/>\n<span style=\"color:#3D44AC; font-size:16px;\">Funding body: <\/span>Instituto de Salud Carlos III &#8211; Cofinanciado FEDER<br \/>\n<span style=\"color:#3D44AC; font-size:16px;\">Principal Investigator: <\/span>Carlos Solano Vercet<br \/>\n<span style=\"color:#3D44AC; font-size:16px;\">Duration: <\/span>2016 &#8211; 2019<br \/>\n<span style=\"color:#3D44AC; font-size:16px;\">Total budget: <\/span>116.765 \u20ac\n<\/div>\n<\/div>\n<\/div><\/div><\/div>\n<\/div><\/div><style type=\"text\/css\">.fusion-body .fusion-builder-column-3{width:100% !important;margin-top : 0px;margin-bottom : 20px;}.fusion-builder-column-3 > .fusion-column-wrapper {padding-top : 0px !important;padding-right : 0px !important;margin-right : 1.92%;padding-bottom : 0px !important;padding-left : 0px !important;margin-left : 1.92%;}@media only screen and (max-width:1532px) {.fusion-body .fusion-builder-column-3{width:100% !important;order : 0;}.fusion-builder-column-3 > .fusion-column-wrapper {margin-right : 1.92%;margin-left : 1.92%;}}@media only screen and (max-width:640px) {.fusion-body .fusion-builder-column-3{width:100% !important;order : 0;}.fusion-builder-column-3 > .fusion-column-wrapper {margin-right : 1.92%;margin-left : 1.92%;}}<\/style>\n<\/div>\n<style type=\"text\/css\">.fusion-body .fusion-flex-container.fusion-builder-row-3{ padding-top : 2%;margin-top : 0px;padding-right : 0px;padding-bottom : 0px;margin-bottom : 0px;padding-left : 0px;}<\/style><\/div><br \/>\n<div class=\"fusion-fullwidth fullwidth-box fusion-builder-row-4 fusion-flex-container nonhundred-percent-fullwidth non-hundred-percent-height-scrolling\" style=\"background-color: #e5e5e5;background-position: center center;background-repeat: no-repeat;border-width: 0px 0px 0px 0px;border-color:#e2e2e2;border-style:solid;\" ><div class=\"fusion-builder-row fusion-row fusion-flex-align-items-flex-start\" style=\"max-width:1248px;margin-left: calc(-4% \/ 2 );margin-right: calc(-4% \/ 2 );\">\n<div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-4 fusion_builder_column_1_1 1_1 fusion-flex-column\"><div class=\"fusion-column-wrapper fusion-flex-justify-content-flex-start fusion-content-layout-column\" style=\"background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;padding: 0px 0px 0px 0px;\">\n<div class=\"fusion-text fusion-text-7\" style=\"transform:translate3d(0,0,0);\"><h5>+ Info<\/h5>\n<\/div>\n<div class=\"fusion-tabs fusion-tabs-3 classic horizontal-tabs icon-position-left\"><style type=\"text\/css\">.fusion-tabs.fusion-tabs-3 .nav-tabs li a.tab-link{border-top-color:#f9f9fb;background-color:#f9f9fb;}.fusion-tabs.fusion-tabs-3 .nav-tabs{background-color:#ffffff;}.fusion-tabs.fusion-tabs-3 .nav-tabs li.active a.tab-link,.fusion-tabs.fusion-tabs-3 .nav-tabs li.active a.tab-link:hover,.fusion-tabs.fusion-tabs-3 .nav-tabs li.active a.tab-link:focus{border-right-color:#ffffff;}.fusion-tabs.fusion-tabs-3 .nav-tabs li.active a.tab-link,.fusion-tabs.fusion-tabs-3 .nav-tabs li.active a.tab-link:hover,.fusion-tabs.fusion-tabs-3 .nav-tabs li.active a.tab-link:focus{background-color:#ffffff;}.fusion-tabs.fusion-tabs-3 .nav-tabs li a:hover{background-color:#ffffff;border-top-color:#ffffff;}.fusion-tabs.fusion-tabs-3 .tab-pane{background-color:#ffffff;}.fusion-tabs.fusion-tabs-3 .nav,.fusion-tabs.fusion-tabs-3 .nav-tabs,.fusion-tabs.fusion-tabs-3 .tab-content .tab-pane{border-color:#e2e2e2;}<\/style><div class=\"nav\"><ul class=\"nav-tabs nav-justified\" role=\"tablist\"><li class=\"active\"><a class=\"tab-link\" data-toggle=\"tab\" role=\"tab\" aria-controls=\"tab-5ee185df6ba8dfe9521\" aria-selected=\"true\" id=\"fusion-tab-thesis\" href=\"#tab-5ee185df6ba8dfe9521\"><h4 class=\"fusion-tab-heading\">THESIS<\/h4><\/a><\/li><\/ul><\/div><div class=\"tab-content\"><div class=\"nav fusion-mobile-tab-nav\"><ul class=\"nav-tabs nav-justified\"><li class=\"active\"><a class=\"tab-link\" data-toggle=\"tab\" role=\"tab\" aria-controls=\"tab-5ee185df6ba8dfe9521\" aria-selected=\"true\" id=\"mobile-fusion-tab-thesis\" href=\"#tab-5ee185df6ba8dfe9521\"><h4 class=\"fusion-tab-heading\">THESIS<\/h4><\/a><\/li><\/ul><\/div><div class=\"tab-pane fade fusion-clearfix in active\" role=\"tabpanel\" tabindex=\"0\" aria-labelledby=\"fusion-tab-thesis\" id=\"tab-5ee185df6ba8dfe9521\"><span style=\"color:#3D44AC; font-size:16px;\">Title: <\/span>Impacto de la alorreactividad NK en el trasplante haploid\u00e9ntico de progenitores hematopoy\u00e9ticos asociado al uso de la ciclofosfamida postrasplante<br \/>\n<span style=\"color:#3D44AC; font-size:16px;\">Doctoral candidate: <\/span>Luis Hidalgo, M\u00aa Mar<br \/>\n<span style=\"color:#3D44AC; font-size:16px;\">Director(s): <\/span>Solano Vercet, Carlos; Pi\u00f1ana S\u00e1nchez, Jose Luis; Planelles Silvestre, Dolores<br \/>\n<span style=\"color:#3D44AC; font-size:16px;\">Date of the defense: <\/span>21\/12\/2022<br \/>\n<span style=\"color:#3D44AC; font-size:16px;\">University: <\/span>Universitat de Val\u00e8ncia<\/p>\n<p><span style=\"color:#3D44AC; font-size:16px;\">Title: <\/span>Significado pron\u00f3stico de la expresi\u00f3n del factor de crecimiento endotelial vascular (VEGF) y de genes implicados en las v\u00edas de se\u00f1alizaci\u00f3n del VEGF en pacientes con leucemia aguda mielobl\u00e1stica<br \/>\n<span style=\"color:#3D44AC; font-size:16px;\">Doctoral candidate: <\/span>Calabuig Mu\u00f1oz, Marisa<br \/>\n<span style=\"color:#3D44AC; font-size:16px;\">Director(s): <\/span>Tormo D\u00edaz, Mar; Solano Vercet, Carlos<br \/>\n<span style=\"color:#3D44AC; font-size:16px;\">Date of the defense: <\/span>04\/05\/2022<br \/>\n<span style=\"color:#3D44AC; font-size:16px;\">University: <\/span>Universitat de Val\u00e8ncia<\/p>\n<p><span style=\"color:#3D44AC; font-size:16px;\">Title: <\/span>Estudio de la enfermedad residual m\u00ednima en pacientes con mieloma m\u00faltiple en muy buena respuesta parcial o completa convencional mediante citometr\u00eda de flujo de alta sensibilidad y la medici\u00f3n de cadenas mediante la t\u00e9cnica Hevylite<br \/>\n<span style=\"color:#3D44AC; font-size:16px;\">Doctoral candidate: <\/span>Remigia Pellicer, Mar\u00eda Jos\u00e9<br \/>\n<span style=\"color:#3D44AC; font-size:16px;\">Director(s): <\/span>De la Rubia Comos, Javier; Sempere Talens, Amparo; Solano Vercet, Carlos<br \/>\n<span style=\"color:#3D44AC; font-size:16px;\">Date of the defense: <\/span>04\/06\/2021<br \/>\n<span style=\"color:#3D44AC; font-size:16px;\">University: <\/span>Universitat de Val\u00e8ncia<\/p>\n<\/div><\/div><\/div>\n<\/div><\/div><style type=\"text\/css\">.fusion-body .fusion-builder-column-4{width:100% !important;margin-top : 0px;margin-bottom : 20px;}.fusion-builder-column-4 > .fusion-column-wrapper {padding-top : 0px !important;padding-right : 0px !important;margin-right : 1.92%;padding-bottom : 0px !important;padding-left : 0px !important;margin-left : 1.92%;}@media only screen and (max-width:1532px) {.fusion-body .fusion-builder-column-4{width:100% !important;order : 0;}.fusion-builder-column-4 > .fusion-column-wrapper {margin-right : 1.92%;margin-left : 1.92%;}}@media only screen and (max-width:640px) {.fusion-body .fusion-builder-column-4{width:100% !important;order : 0;}.fusion-builder-column-4 > .fusion-column-wrapper {margin-right : 1.92%;margin-left : 1.92%;}}<\/style>\n<\/div>\n<style type=\"text\/css\">.fusion-body .fusion-flex-container.fusion-builder-row-4{ padding-top : 2%;margin-top : 0px;padding-right : 0px;padding-bottom : 0px;margin-bottom : 0px;padding-left : 0px;}<\/style><\/div><\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"100-width.php","meta":[],"acf":[],"_links":{"self":[{"href":"https:\/\/tst.incliva.es\/en\/wp-json\/wp\/v2\/pages\/7534"}],"collection":[{"href":"https:\/\/tst.incliva.es\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/tst.incliva.es\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/tst.incliva.es\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/tst.incliva.es\/en\/wp-json\/wp\/v2\/comments?post=7534"}],"version-history":[{"count":0,"href":"https:\/\/tst.incliva.es\/en\/wp-json\/wp\/v2\/pages\/7534\/revisions"}],"wp:attachment":[{"href":"https:\/\/tst.incliva.es\/en\/wp-json\/wp\/v2\/media?parent=7534"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}